Health ❯ Medicine ❯ Infectious Diseases
COVID-19 Virus-Killing Surfaces H5N1 Avian Influenza Epstein-Barr Virus Ebola Virus
Researchers say the preclinical results open a path to a broad-spectrum antiviral by focusing on a conserved viral vulnerability.